PHENOMAPS Trademark

Trademark Overview


On Monday, December 14, 2020, a trademark application was filed for PHENOMAPS with the United States Patent and Trademark Office. The USPTO has given the PHENOMAPS trademark a serial number of 90379489. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2023. This trademark is owned by Inzen Therapeutics, Inc.. The PHENOMAPS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
phenomaps

General Information


Serial Number90379489
Word MarkPHENOMAPS
Filing DateMonday, December 14, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 14, 2021

Trademark Statements


Goods and ServicesPharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSONATA THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Party NameInzen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameInzen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, April 25, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 25, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 3, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 3, 2022SOU EXTENSION 1 FILED
Wednesday, August 3, 2022TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 14, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 14, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 24, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 23, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 23, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 29, 2021NON-FINAL ACTION E-MAILED
Monday, March 29, 2021NON-FINAL ACTION WRITTEN
Wednesday, March 17, 2021ASSIGNED TO EXAMINER
Sunday, February 21, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED